Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history adds a new revision entry for v3.6.5, replacing the previous v3.6.4, indicating a page metadata update rather than a change to study records.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new Revision: v3.6.4 is now listed in the study record history, replacing the previous Revision: v3.6.3. This reflects a minor update to the page interface rather than changes to the study data.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.3 has been added to the study's history, superseding the previous v3.6.2 entry.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history section now shows a newer software revision (v3.6.2) replacing the older v3.6.0, indicating a background deployment that updates how history is displayed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record now shows the study is Completed and no longer looking for participants, with the Recruitment Status and Study Status sections updated accordingly to reflect the end of recruitment.SummaryDifference2%

- Check78 days agoChange DetectedA new revision entry Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This indicates an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.